Brain-derived neurotrophic factor or neurotrophin-4/5 to treat periodontal diseases and pulpal diseases
AssigneesTwo Cells Co., Ltd., Hidemi Kurihara
InventorsHidemi Kurihara, Hiroyuki Kawaguchi, Katsuhiro Takeda, Hideki Shiba, Noriyoshi Mizuno, Hiroshi Yoshino, Naohiko Hasegawa, Hiroaki Shinohara
Life of this patent
Estimating the term…
Abstract
The objects of the present invention are: to provide a therapeutic agent and a therapeutic method for periodontal diseases and pulpal diseases, a transplant for periodontal tissue regeneration, and a method for regenerating the periodontal tissue. According to the present invention, there are provided therapeutic agents for periodontal diseases and pulpal diseases which comprise neurotrophic factors as an active ingredient.
Claims8
A method for treatment of periodontal disease which comprises administering a transplant comprising:
- a therapeutically effective amount, per tooth or defect, of a neurotrophic factor for regenerating periodontal tissues, and
- a sheet or sponge impregnated with the neurotrophic factor, comprising a biodegradable protein material and a tissue absorbing material,
- to a subject who is suffering or prone to suffer from the disease in order to regenerate periodontal tissues, wherein the neurotrophic factor is a brain-derived neurotrophic factor or neurotrophin-4/5, wherein the therapeutically effective amount is in the range of 1×10−12 g to 1×10−3 g per tooth or defect, and wherein the biodegradable protein material is selected from the group consisting of collagen, gelatin, albumin, and platelet-rich plasma (PRP), and the tissue absorbing material is selected from the group consisting of hyaluronic acid (HA) and tricalcium phosphate (TCP).
Dependencies are inferred from the claim text.